**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY (A Company limited by guarantee** ) 

## **REPORT AND FINANCIAL STATEMENTS** 

**FOR THE YEAR ENDED 31 DECEMBER 2020** 

**Company No: 5483950 Charity No: 1111288** 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|**CONTENTS**|**Pages**|
|---|---|
|Legal and administrative information|1|
|report|2<br> 9|
||10 - 12|
|Statement of Financial Activities|13|
|Balance sheet|14|
|Cash Flow Statement|15|
|Notes to the financial statements|16 - 23|





**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **LEGAL AND ADMINISTRATIVE INFORMATION** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **LEGAL AND ADMINISTRATIVE INFORMATION** 

## **General Information** 

EASO Level 2, 8 Waldegrave Road Teddington TW11 8GT United Kingdom 

## **Registered Office** 

Haysmacintyre LLP 10 Queen Street Place London EC4R 1AG 

enquiries@easo.org www.easo.org 

Registered Charity No: 1111288 Company No: 5483950 

## **Current Executive Committee (Trustees)** 

President: President-Elect: Secretary: Treasurer: Regional Vice President Northern Region: Regional Vice President Middle Region: Regional Vice President Southern Region: 

Nathalie Farpour-Lambert (Switzerland) Jason Halford (UK) Paolo Sbraccia (Italy) Jørn Sagen (Norway) Dana Mullerova (Czech Republic) Volkan Yumuk (Turkey) 

## **Ex Officio** 

Childhood Obesity Task Force Chair: 

Obesity Management Task Force Chair: Prevention and Public Health Task Force Chairs: Scientific Advisory Board Chair: Executive Director/Company Secretary: 

Jennifer Baker (Denmark) and Jens-Christian Holm (Denmark) Luca Busetto (Italy) and Dror Dicker (Israel) Daniel Cauchi (Malta) and Janas Harrington (Ireland) Gema Frühbeck (Spain) and Gijs Goossens (Netherlands) Euan Woodward (UK) 

## **Auditor** 

Haysmacintyre LLP 10 Queen Street Place London EC4R 1AG 

## **Solicitor** 

Bates Wells & Braithwaite 2-6 Cannon Street London EC4M 6YH DX 42609 

## **Bank** 

HSBC Bank plc (UK) 156 - 157 Tottenham Court Road London    W17 7AY 

1 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

The Trustees, who are also Directors of the Charity for the purposes of the Companies Act, submit their Annual Report and the audited financial statements for the year ended 31 December 2020. The Trustees have 

the provisions of the Statement of Recommended Practice (SORP) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective October 2019)". 

## **Objectives and activities** 

## **EASO Overview** 

Established in 1986, EASO is a federation of professional membership associations from 36 European countries. It is the voice of European obesity professionals, representing a community of over 20,000 scientists, health care practitioners, physicians, public health experts, early career researchers, students and patients.  EASO is in formal relations with the World Health Organisation (WHO) Regional Office for Europe, coordinates the EU Obesity Policy Engagement Network (OPEN) and is a member of the EU Health Coalition and the Biomedical Alliance in Europe. 

EASO promotes action through collaboration in research, education and policy. 

The actions of EASO support the membership and wider community in the most effective and impactful way possible. The **objectives** of EASO are: 


- To establish obesity as an urgent and relevant health and wellbeing priority 


- To develop evolving evidence-based approaches for preventing and treating obesity across the lifespan To promote effective solutions through research, education and policy. 


## We meet these **Objectives** through: 


- Promoting excellence and dissemination in research and its translation for improving health and wellbeing Providing knowledge and skills to improve the quality, availability and access to healthcare Informing and influencing policy across sectors 




- Collaborating with key stakeholders 


- Supporting EASO member countries and enabling the establishment of new member societies. 

EASO continues to concentrate its activities in the areas of research, education and policy, and in 2019 placed a greater emphasis on policy impact, especially at the European level.  EASO also dedicated efforts to support the development of national advocacy activities, within member countries and through the COMs network. 

## **Public Benefit Statement** 

The Trustees of EASO confirm that they have complied with the duty in Section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission in determining the activities undertaken by the Charity. 

## **Achievements and performance** 

Overview:  As with many organisations, 2020 has been dominated by Covid-19, which has a particularly important impact on obesity and people living with obesity.  EASO had to cancel or postpone live events from March 2020, starting with our influential European Policy Conference, but we adapted very quickly in order to provide patient resources, member training, technical webinars and policy advice.  We published several position statements and policy statements, ensuring that obesity was prioritised in Covid-19 related discussion and policy decision making. EASO converted our annual congress and several training events online, working with our congress partner to develop a sophisticated online congress platform which was used throughout 2020 and into 2021.  EASO supported the patient community of ECPO (European Coalition for People Living with Obesity) to provide several covid resources and support webinars.  The EASO Executive Committee is proud of our 2020 achievements, our ability to adapt, and our provision of support to our membership, wider networks and patient community. 

2 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

EASO undertakes its strategic actions under three key pillars: research; education; and policy.  Despite Covid-19, many activities continued in an adapted format and indeed several achievement, particularly in the policy stream, are reported below. 

## **1) Research** 

EASO participates in EU funded research consortia as a dissemination and stakeholder engagement partner.  In 2020 EASO was involved in 4 ongoing projects (2 funded under the Horizon 2020 mechanism and 1 funded under the IMI mechanism).   EASO is the dissemination work package leader H2020 Project NoHoW, which ended in February 2020. EASO is also a member of the H2020 PROTEIN and SWEET consortia which are also H2020 funded and which commenced in late 2018.  PROTEIN is a 3 year project and SWEET is a 5 year project, however both are likely to be extended due to the Covid-19 pandemic impacting the ability of the consortia to undertake their research trials effectively/.  EASO is also a dissemination and stakeholder engagement partner in the 5 year IMI funded SOPHIA research project, which commended in June 2020. 

In 2020 EU facilitated EU Project dissemination and networking by creating presentation opportunities at our annual European Congress on Obesity (ECO-ICO2020) and via EASO social media and member network channels.  Participating projects were offered programme session time and free e-exhibition space in order to showcase their project concepts, results and recommendations.  EASO was also a member of several project proposals in 2020, with funding results due in 2021. 

In 2020 EASO also funded two research projects (SWIM-c and EUROPEANS) which investigate the impact of Covid-19 on people living with obesity.  These are research collaborations undertaken with researchers at the University of Leeds, Liverpool and Cambridge (UK).  Results from these projects will inform policymakers and identify areas for further research, patient support (practical resources and communications). 

The EASO Scientific Advisory Board (SAB) continues to be active and in EASO strategic planning, ensuring that scientific research is represented adequately in EASO activities such as our European Congress on Obesity, New Investigators United Autumn School and Train the Trainer Teaching School.  The SAB has been active in 2020 in the development of policy statements, member update webinars and practical recommendations related to Covid-19 and obesity. 

## **Informing European Research** 

EASO regularly meets with EU Commission representatives to promote obesity research, and in 2020 was invited by DG Research and Innovation to submit a formal research gap analysis and priority recommendation paper this will be used to help prioritise research funding and to inform policy decision making. 

## **2) Education** 

In 2019 EASO provided over 15000 hours of live training.  The provision of live training was not possible throughout 2020, but EASO adapted quickly and converted several teaching programmes into digital alternatives. 

## **The European Congress on Obesity** 

The 2020 ECO (ECO-ICO2020) was jointly hosted with World Obesity (WOF) and the Association for the Study of Obesity in Ireland (ASOI) and originally scheduled to take place in Ireland in May 2020.  The congress was first postponed and then converted online, and hosted on the specially developed EASO congress platform from 1-4 September 2020.  The congress was a success scientifically and financially: 

- The ECO-ICO was an International platform for education, dissemination and networking 

- It attracted 3000+ online delegates, from over 75 countries 

- All sessions were automatically recorded with instant replay available to delegates for 3 months 

- EASO will develop a highlight show for targeted audiences 

- The ECO-ICO incorporated Covid-19 related policy discussions and EASO hosted several advocacy training sessions during the congress 

- There was a significant international media coverage and social media following 

3 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **2020 EASO Train the Trainer Summer School** 

The EASO aims to deliver high level multidisciplinary training in the treatment and prevention of obesity, in order to identify and develop national experts who will be certified to standardized education tools at the local level.  The 5 day training school was scheduled to take place at the Foundation residential training centre near Annecy, France in July 2020.  It was not possible to host a r allowing EASO to accept high delegate numbers and cover a wider range of topics.  In summary: 

- The live event was cancelled and converted to digital, hosted via the specially developed EASO online congress platform 

- The format was 

- There was Joint Plenary Session covering key issues related to both topic streams 

- EASO hosted 6 topic specific webinars in Adult track (12 hours of training) 

- EASO 4 topic specific webinars in Child/Adolescent track (8 hours of training) 

- All sessions were recorded with instant replay available to delegates for 3 months 

- >100 participants were accepted via a competitive application process 

## **2020 EASO New Investigators United Autumn School** 

In 2020 EASO planned to host a 3- n was to provide early career colleagues with a comprehensive overview of obesity.  The programme addressed a range of topics covering basic/discovery science; public health/prevention; and clinical management.  The In summary: 

- The live autumn school event was cancelled and converted to a digital winter school, hosted via the specially developed EASO online congress platform 

- The NIU ECO travel grants were postponed to 2021 and subsequently 2022 

- The winter school format was adapted to take place over 2 days with 15 sessions (12 hours of education) including delegate poster discussions, networking and video presentation 

- All sessions were recorded with instant replay available to delegates for 3 months 

- 40 participants were accepted via a competitive application process 

- The EASO New Investigators United Best Thesis Award was presented during the digital winter school 

The NIU received >75 award applications in 2020.  ECO travel grants were not relevant with a digital congress, but EASO offered >40 complimentary ECO-ICO registrations to NIU applicants. 

EASO presented the following scientific awards at ECO-ICO2020: New Investigator Award in Basic Science New Investigator Award in Clinical Research New Investigator Award in Public Health New Investigator Award in Childhood Obesity 

## **EASO Collaborating Centres for Obesity Research (COMs)** 

The EASO COMs network continued to develop in 2020, the network now comprises over 150 Accredited Centres from outside Europe that have been accredited following COMs Exchange and Mentoring programme participation.  The 2020 COMs Exchange and Mentoring Programme and the 2020 COMs Summit were postponed, likely to next take place in 2022.  EASO continued to offer COMs educational workshops however, using digital formats with sessions held throughout 2020.  EASO hosted 4 OMTF webinars (6 hours of education) hosted in 2020, with over 750 attendees.  Topics - - -1 were hosted for COMs network members and the wider scientific and clinical communities. 

4 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

where users will learn how to establish and develop a multidisciplinary treatment centres, and where they will be able to follow care pathways using several case study digital adaptations. 

## **3)  Policy and Advocacy** 

EASO significantly increased activity in this area during 2020.  EASO is now an active member of several EU coalitions, notably the EU Health Coalition and OPEN EU, where EASO is the scientific secretariat.  With permanent representation in Brussels, EASO is now able to react to fast moving policy opportunities and to influence policy discussions and decision making.  EASO has been able to influence several policy initiatives at the European level throughout 2020, leading to significant recognition of obesity as a disease in 2021. 

EASO supported the launch of OPEN EU (Obesity Policy Empowerment Network) in March 2020.  Originally scheduled to launch with an official event at the European Parliament, the launch was converted to a digital event attended by MEPs, European and International institution representatives, EASO and ECPO representatives, and several other interested stakeholders.  EASO also commission a special supplement in Politico where the OPEN EU manifesto was launched.   OPEN EU was active throughout 2020, attracting several stakeholder members, and supporting the work of OPEN Global and several national OPEN networks. 

In 2020 EASO started to host regular policy update webinars, our Advocacy Stakeholder events, and hosts regular were attended by 40 international participants with an interest in developing their own advocacy campaign at a national 2020. 

## **2020 European Obesity Day Campaign (EOD)** 

e aim of which is to increase knowledge and understanding of the need for action at both European and national levels to improve prevention, treatment and care in obesity.   The 2020 EASO Policy Conference, scheduled to take place in Brussels in March 2020, was cancelled due to Covid-19.  EASO hosted several webinars instead, mostly related to obesity and covid-19, the first of which attracted over 1000 registrations. 

## **EASO Social Media: 2020** 

During the past 12 months, EASO social media has continued to move from strength to strength.  We manage social media accounts for the primary EASO brand across Twitter, Facebook and LinkedIn, as well as the ED LinkedIn profile and the Twitter and FaceBook presence of the New Investigators United, the EASO ECPO and EU projects NoHoW, PROTEIN and SWEET.  We also use social media to drive the 2020 World Obesity Day Europe campaigns, to promote ECO, EASO publications and to host TweetChats across our live streamed Policy Conference and media events at ECOICO2020. We use these social media platforms to educate and inform, share EASO focused content, collaborate with partner organisations and improve access to our growing range of educational and training tools. The EASO brand following continues to advance, and we now have over 10,000 Twitter followers - including high-profile KOLs, organisations and companies in the primary account, with thousands more across our affiliated Twitter and Facebook communities. 

## **Membership** 

EASO exists to serve its members and welcomed 2 new members in 2020, Azerbaijan and Bosnia-Herzegovina.   This takes the membership to 36 European countries, via affiliated National Obesity Associations, representing over 5000 obesity professionals.  EASO communicates with its membership via its website; e-newsletters (distribution >22,500); direct communications; and ECO meetings.  EASO also prepares scientific statements/guidelines which are shared with and translated by members.  EASO also provides resources to members, in the form of European/World Obesity Day materials and communication support.  EASO members are active in the strategic development of the society, leading to the development of actions that meet membership needs and help to develop member knowledge and skills. 

5 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **Finance Review** 

At the end of the year to 31 December 2020, the charity total funds stood at £769,492 (2019: £1,143,551) and £568,732 related to Unrestricted funds (2019: £989,564). The balance related to  restricted funds at the year-end  £200,760 (2019: £153,987 **).** The difference in income from 2019 is due to deferment of projects (and therefore related income via project specific funding) due to Covid-19 restrictions. Indeed, some deferred projects are likely to be postponed again until 2022. Total expenditure in 2020 amounted to £1,148,108 compared to £1,534,052 in 2019.  This reduction is due to a reduction in completed projects and a cost saving generated from conversion of some projects from face-to-face to digital. Operational costs have also been reduced due to digital conversion, and this will continue through 2021. 

## **EASO Reserve Policy** 

In order to secure the viability of the organisation beyond the immediate future, to provide reliable service and required funding over the longer term, EASO must be able to absorb financial setbacks. It is therefore necessary to set aside some of the current income as a reserve against future uncertainties. 

In view of the financial needs of the organisation, the trustees have agreed to maintain a reserve policy to retain sufficient funds to cover the operating expenses of the organisation for one year, covering core staff and operational costs. The reserve would cover: secretariat expenditure, supporting funds for agreed projects, agreed loan for ECO conference, and other liabilities such as executive travel expenses, legal expenses, and other miscellaneous expenses that are necessary for the operation of the charity.  The reserves level held meets the current requirement set by the executive committee. 

The trustees will review the reserve policy at its 1[st] executive committee meeting each year to ensure that: 1) the policy is adequate for its need in the coming year; 2) reserve level is enough to cover one year operating expenditure; 3) take necessary steps if reserve falls short of the funding requirement. 

## **Risk Management** 

EASO has a formal risk management process through which the major risks to which the organisation may be exposed and has ranked these by likelihood and impact, culminating in a risk control document which is updated on a regular basis. All significant risks, together with current mitigation actions, are reviewed regularly throughout the year by the Trustees. The Trustees are satisfied that systems have been developed and are in place to mitigate identified risks to an acceptable level. 

6 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

The principal risks and uncertainties identified by the charity are as follows: 


**----- Start of picture text -----**<br>
Risk identified  Action taken to mitigate the risk<br>Covid-19  Covid-19 has had a significant impact globally, and initially<br>posed a serious risk to EASO due to the cancellation of its<br>2020 scientific congress.  However, all costs were<br>recovered and live events have been converted to digital.<br>Now that the initial congress risk has been managed,<br>EASO has managed to perform well with digital solutions<br>so ongoing risk is minimised.<br>Loss of key personnel  Development  of  a  comprehensive  protocol  and<br>contingency document that all Trustees have access to<br>and can use to maintain project work in the event of loss<br>of key personnel.  Training of trusteed partner consultants<br>who may be called upon to undertake key tasks in the<br>event of loss of key personnel.<br>Operational risks related to delivery of Congress and  Operational risk assessments undertaken and mitigation<br>Projects  procedures identified and regularly reviewed.  Policies<br>and  procedures  are  regularly  reviewed  and<br>updated.  Electronic data back-up systems reviewed and<br>updated regularly.<br>Reputational risk  Trustees and the Executive Director regularly review the<br>external environment and evaluate the potential impact<br>on the organisation.  Regular communication with the<br>EASO General Council on this matter, to ensure support of<br>policies.<br>Law, regulation and compliance risks  Trustees and Senior Management team keep up to date<br>on legal and regulation issues through attendance at<br>training, conferences and through professional bodies to<br>which they are affiliated. Action is taken as necessary.<br>**----- End of picture text -----**<br>


## **Future Plans** 

The EASO Executive Committee conducts regular critical reviews of its objectives, the most recent taking place in 2019. EASO has adapted very well to the global situation created by the Covid-19 pandemic, converting its comprehensive education and advocacy programmes into dynamic digital alternatives that attract wide audiences and are cost effective to implement.  The EASO Executive Committee continuously evaluates priority actions and the EASO organisational structure has the flexibility to adapt to fast changing environments and opportunities. 

We will launch new Working Groups in Physical Fitness and Function, and in Psychology, ensuring that we represent and influence an even wider community of obesity specialists and professionals.  We will continue to develop and publish recommendations, guidelines and policy statements. 

In 2021 EASO will continue to focus on education and research, where several long term projects will be implemented digitally.  New projects, taking advantage of our increasing digital experience will be launched.  We will host our European Congress on Obesity digitally and are confident of attracting high delegate numbers and significant sponsor participation. We will host a full programme of teaching webinars and stakeholder courses with partner societies. 

In 2021 we will have a particular focus on policy and advocacy.  We will again host World Obesity Day Europe with a sity training courses and national and regional policy clinics.  We aim in 2021 to develop significant recognition of obesity as a chronic relapsing disease, to lead policy discussions and developments in our field, and to support policy action at the national level across Europe. 

7 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **The Structure of European Association for the Study of Obesity** 

Articles of Association.  The association is managed by its Executive Committee which reports to its General Council.  The Trustees of EASO are the officers of the Executive Committee. 

The Executive Committee Members shall each hold office from the close of the Annual General Council meeting at which they are appointed to the close of the relevant Annual General Council Meeting at which their successor is appointed, unless they are reappointed by the General Council for a further non-renewable term. 

Members of the Executive Committee are elected by the General Council.  Nominations for election to the office of the President, President Elect, Secretary, Treasurer and Regional Vice President shall be submitted to each Adhering Body by Additional nominations may be submitted on behalf of Adhering Bodies at least one month prior to the meeting of the General Council. 

Save in the case of Regional Vice Presidents, election of the Executive Committee shall be by secret ballot with a majority vote of those present required for election. Should there be more than 2 nominations, the nominee with least votes in each round will be deleted until a nominee receives a majority vote. 

Regional Vice Presidents shall be elected by secret ballot of the delegates of Adhering Bodies in the relevant region (as determined by the Executive Committee) at a meeting of the General Council. The Executive Committee may with approval of the General Council vary the number of regions represented. 

If a casual vacancy arises in the office of President, President Elect, Secretary, Treasurer or Regional Vice President, this shall be filled by the Executive Committee for the unexpired term of office. 

Upon appointment, Trustees receive a comprehensive Trustee Procedural Manual and are offered regular independently delivered Trustee Training.  Day to management of the organisation is deferred to the Executive Director who manages operational and project delivery via a team of consultants and agencies based in the UK and Brussels, with Trustee consultation where appropriate.  Pay of key management is determined through consultation with the Executive Director and Treasurer, with majority Trustee approval. 

The General Council (voting membership) of EASO shall comprise the Adhering Bodies - the principal national society, academy, national research council or other appropriate scientific group for the study of obesity whose aims meet the objectives of EASO and which is duly recognised and approved by the Executive Committee as the Adhering Body designated for any European country. No nation may have more than one Adhering Body, but an Adhering Body may represent multiple countries. 

8 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **TRUSTEES REPORT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **Responsibilities of Trustees** 

The Trustees, as directors of the charitable company, are responsible for preparing the Trustees Report and the financial statements in accordance with applicable law and regulations. 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: 

select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgments and accounting estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

So far as each of the directors is aware at the time the report is approved: 

- there is no relevant audit information of which the company's auditors are unaware; and 

- the directors have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditors are aware of that information. 

Approved by the Trustees on and signed on their behalf by 

## Paolo Sbraccia 

Trustee 

9 



## **EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **Opinion** 

We have audited the financial statements of European Association for the Study of Obesity for the year ended 31 December 2020 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). 

In our opinion, the financial statements: 

- give a true and fair view of the stat 

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordance with the requirements of the Companies Act 2006. 

## **Basis for opinion** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## **Conclusions relating to going concern** 

in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report. 

## **Other information** 

The trustees are responsible for the other information. The other information comprises the information included in the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.  We have nothing to report in this regard. 

## **Opinions on other matters prescribed by the Companies Act 2006** 

In our opinion, based on the work undertaken in the course of the audit: 

- purposes of company law) for the financial year for which the financial statements are prepared is consistent with the financial statements; and 

- applicable legal requirements. 

10 



## **EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **Matters on which we are required to report by exception** 

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course report). 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: 

- adequate accounting records have not been kept by the charitable company; or the charitable company financial statements are not in agreement with the accounting records and returns; or 

- we have not received all the information and explanations we require for our audit; or the trustees w 

- requirement to prepare a strategic report. 

## **Responsibilities of trustees for the financial statements** 

set out on page 9 the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the trustees are responsible for assessing the charitable continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whethe Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: 

Based on our understanding of the group and the environment in which it operates, we identified that the principal risks of non-compliance with laws and regulations related to regulatory requirements for GDPR, Charities Act 2011 and Companies Act 2006, and we considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the preparation of the financial statements such as the Companies Act 2006, the Charities Act 2011, income tax and payroll tax. 

financial statements 

(including the risk of override of controls), and determined that there was a very limited risk as Haysmacintyre prepare the accounts and post the year end journals, there are also few estimates and judgements involved in preparing the accounts.  Audit procedures performed by the engagement team included: 

- Inspecting correspondence with regulators and tax authorities; 

- Discussions with management including consideration of known or suspected instances of non-compliance with laws and regulation and fraud; 

- 

- Identifying and testing journals, in particular journal entries posted with unusual account combinations, postings by unusual users or with unusual descriptions; and 

- Challenging assumptions and judgements made by management in their critical accounting estimates. 

11 



## **EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting www.frc.org.uk/auditorsresponsibilities. This 

## **Use of our report** 

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members, as a body, for our audit work, for this report, or for the opinions we have formed. 


Kathryn Burton (Senior Statutory Auditor) 

For and on behalf of Haysmacintyre LLP, Statutory Auditor 10 Queen Street Place 

London EC4R 1AG 

12 



## **EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **STATEMENT OF FINANCIAL ACTIVITIES (Incorporating Income and Expenditure account)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|||||**2020**|**2019**|
|---|---|---|---|---|---|
|||**Restricted**|**Unrestricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**Funds**|**Funds**|
|**INCOME FROM:**|**Notes**|**£**|**£**|**£**|**£**|
|**Donations and Membership income**||-|16,401|16,401|4,704|
|**Charitable Activities:**||||||
|Policy, Research & Education|2|76,258|681,390|757,648|2,007,695|
|||**-------------------**|**-------------------**|**-------------------**|**-------------------**|
|**Total**||76,258|697,791|774,049|2,012,399|
|||**-------------------**|**-------------------**|**-------------------**|**-------------------**|
|**EXPENDITURE ON:**||||||
|**Charitable expenditure:**||||||
|Policy, Research & Education|3|29,485|1,118,623|1,148,108|1,534,052|
|||**------------------**|**------------------**|**------------------**|**------------------**|
|**Total**||29,485|1,118,623|1,148,108|1,534,052|
|||**------------------**|**------------------**|**------------------**|**------------------**|
|**Net movement in funds**|5|46,773|(420,832)|(374,059)|478,347|
|**Transfer between funds**||-|-|-|-|
|**Reconciliation of funds**||||||
|Total funds brought forward||153,987|989,564|1,143,551|665,204|
|||**--------------**|**--------------**|**-------------------**|**-------------------**|
|**Total funds carried forward**||200,760|568,732|769,492|1,143,551|
|||**=======**|**=======**|**=========**|**=========**|



The statement of financial activities includes all gains and losses recognised in the year. 

All income and expenditure derive from continuing activities. 

Notes on pages 16 to 23 form an integral part of these accounts. 

13 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

**Company Number: 5483950** 

## **BALANCE SHEET** 

## **AS AT 31 DECEMBER 2020** 

|||**Charity**|**Charity**|
|---|---|---|---|
|**CURRENT ASSETS**||||
|Debtors|8|56,263|46,575|
|Cash at bank and in hand||1,733,289|1,131,597|
|||-----------------|-----------------|
|||1,789,552|1,178,172|
|**CREDITORS:**amounts falling due||||
|within one year|9|(1,020,060)|(34,621)|
|||-----------------|-----------------|
|**NET CURRENT ASSETS**||769,492|1,143,551|
|||-----------------|-----------------|
|**NET ASSETS**||769,492|1,143,551|
|||========|========|
|**FUNDS**||||
|Restricted funds|12|200,760|153,987|
|Unrestricted funds|12|568,732|989,564|
|||-----------------|-----------------|
|||769,492|1,143,551|
|||========|========|



The financial statements were approved and authorised for issue by the Trustees on and signed on their behalf, by: 

Paolo Sbraccia 

Trustee 

Notes on pages 16 to 23 form an integral part of these accounts. 

14 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **CASH FLOW STATEMENT** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|||**Total funds**|**Total funds**|**Total funds**|
|---|---|---|---|---|
|||**2020**||**2019**|
||**£**|**£**|**£**|**£**|
|**Cash in flows from operating activities**||601,692||403,376|
|**Cash flows from investing activities:**|||||
|**_Net cash provided by (used in) investing activities_**||-||-|
|||-----------------||-----------------|
|**Increase in cash and cash equivalents in the reporting**||601,692||403,376|
|**period**|||||
|**Cash and cash equivalents at the beginning of the**|||||
|**reporting period**||1,131,597||728,221|
|||--------------------||--------------------|
|**Cash and cash equivalents at the end of the reporting**||1,733,289||1,131,597|
|**period**|||||
|||==========||==========|
||||**2020**|**2019**|
||||**£**|**£**|
|**Reconciliation of net movement in funds to cash flow**|||||
|**from operating activities**|||||
|Net movement in funds|||(374,059)|478,347|
|(Increase)/decrease in debtors|||(9,688)|54,375|
|Increase/(decrease) in creditors|||985,439|(129,346)|
||||---------------------|---------------------|
|**Net cash provided by in investing activities**|||601,692|403,376|
||||==========|==========|
|**Analysis of cash and cash equivalents**|||**2020**|**2019**|
||||**£**|**£**|
|Cash in hand|||1,733,289|1,131,597|
||||-----------------|-----------------|
|**Total cash and cash equivalents**|||1,733,289|1,131,597|
||||========|========|



15 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

**NOTES TO THE FINANCIAL STATEMENTS** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **1. ACCOUNTING POLICIES** 

## **Basis of Preparation** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. 

European Association for the Study of Obesity meets the definition of a public benefit entity under FRS102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. 

## **Going Concern** 

The trustees have assessed the charity's requirements for the foreseeable future as a result the impact of the worldwide Covid-19 pandemic and are confident that sufficient funds will be available to enable administrative operations to continue at a sustainable level for a period of at least 12 months from the date of approval of these financial statements. The charity therefore continues to adopt the going concern basis in preparing its financial statements and the trustees confirm that no material uncertainties exsit. 

## **Company status** 

The company is a company limited by guarantee. The members of the company are the trustees named on page 1. In the event of the company being wound up, the liability in respect of the guarantee is limited to £1 per member of the company. 

## **Fund accounting** 

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes. 

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors which have been raised by the company for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. 

## **Income** 

All income is recognised once the charity has entitlement to income, it is probable that income will be received and the amount of income receivable can be measured reliably. 

## **Membership dues, advertising and publishing royalties** 

Income from membership dues, advertising and publishing royalties are included in the SOFA when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. 

## **Conference organisation and media support** 

Income from conference organisation and media support is included in the SOFA when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. 

relevant running costs. 

16 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

**NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **1. ACCOUNTING POLICIES (continued) Investment income** 

Investment income, including interest receivable, is included when receivable by the charity. 

## **Expenditure** 

All expenditure is accounted for on an accruals basis and has been included under expense categories that aggregate all costs for allocation to activities. Where costs cannot be directly attributed to particular activities they have been allocated on a basis consistent with the use of the resources. Direct costs, including directly attributable salaries, are allocated on an actual basis to the key strategic area of activity. Overheads and other salaries are allocated between the expenses headings on the basis of time spent. 

Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities.  Support costs are those costs incurred directly in support of expenditure on the objects of the Charity and are allocated on the basis of staff cost.  Governance costs are those incurred in connection with enabling the Charity to comply with external regulation, constitutional and statutory requirements and in providing support to the Trustees in the discharge of their statutory duties and are now apportioned on the same basis as the support costs. 

## **Foreign currencies** 

Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction.  Monetary assets and liabilities are retranslated at the rate of exchange ruling at the balance sheet date.  All differences are taken to the SOFA. 

## **VAT** 

The charity is not registered for VAT and expenses therefore include an element of irrecoverable VAT. 

There is no company pension scheme in operation but contributions are paid for the staff member into a personal pension scheme. 

## **Debtors** 

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. 

## **Cash at bank and in hand** 

Cash at bank and cash in hand includes cash and short term highly liquid investments. 

## **Creditors and provisions** 

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due. 

## **Employee benefits** 

## **Short term benefits** 

Short term benefits including holiday pay are recognised as an expense in the period in which the service is received. 

17 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

**NOTES TO THE FINANCIAL STATEMENTS (continued)** 

**FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **1. ACCOUNTING POLICIES (continued)** 

## **Estimates and Judgements** 

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Although these from these estimates. The Trustees do not consider there to be any material estimates and judgements 

## **2.** 

|**CHARITABLE ACTIVITIES**|**Restricted**|**Unrestricted**|**Total funds**|**Total funds**|
|---|---|---|---|---|
||**Funds**|**Funds**|**2020**|**2019**|
||**£**|**£**|**£**|**£**|
|**Research & Education**|||||
|Corporate funded research and education|**-**|429,905|429,905|1,627,574|
|NOHOW income|18,800|-|18,800|32,493|
|Miscellaneous income|-|-|-|76,865|
|Advocacy income|-|251,485|251,485|111,522|
|UOL Collaboration Research Paper|-|-|-|36,305|
|General income|-|-|-|1,231|
|PROTEIN income|36,046|-|36,046|121,705|
|SWEET income|16,638|-|16,638|-|
|SOPHIA income|4,774|-|4,774|-|
||-----------------|------------------|-----------------|-----------------|
||**76,258**|**681,390**|**757,648**|**2,007,695**|
||**========**|**========**|**========**|**========**|
|**2019**|**Restricted**|**Unrestricted**|**Total funds**||
||**Funds**|**Funds**|**2019**||
||**£**|**£**|**£**||
|**Research & Education**|||||
|Corporate funded research and education|**-**|1,627,574|1,627,574||
|NOHOW income|32,493|-|32,493||
|Miscellaneous income|-|76,865|76,865||
|Advocacy income|-|111,522|111,522||
|UOL Collaboration Research Paper|-|36,305|36,305||
|General income|-|1,231|1,231||
|PROTEIN income|121,705|-|121,705||
||-----------------|------------------|-----------------||
||**154,198**|**1,853,497**|**2,007,695**||
||**========**|**========**|**========**||



18 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|**3(a)**|**CURRENT YEAR EXPENDITURE ON**|**Direct**|**Support**|**Total funds**|**Total funds**|
|---|---|---|---|---|---|
|||**Costs**|**Costs**|**2020**|**2019**|
|||**£**|**£**|**£**|**£**|
||**Charitable expenditure**|||||
||Policy & Research|643,748|127,457|771,205|775,870|
||Education<br>Charity|221,121|155,782|376,903|758,182|
|||-------------------|----------------|-------------------|-------------------|
||**Total expenditure**|864,869|283,239|1,148,108|1,534,052|
|||=========|========|=========|=========|
|||**Secretariat &**||**Total costs**|**Total costs**|
|||**Staff costs**|**Other Costs**|**2020**|**2019**|
||**SUPPORT COSTS COMPRISE OF:**|**£**|**£**|**£**|**£**|
||Policy & Research|55,799|71,659|127,458|254,016|
||Education|68,198|87,583|155,781|310,464|
|||----------------|---------------|------------------|------------------|
|||123,997|159,242|283,239|564,480|
|||========|=======|=========|=========|
|**3(b)**|**PRIOR YEAR EXPENDITURE ON**|**Direct**|**Support**|**Total funds**||
|||**Costs**|**Costs**|**2019**||
|||**£**|**£**|**£**||
||**Charitable expenditure**|||||
||Policy & Research|521,854|254,016|775,870||
||Education<br>Charity|447,718|310,464|758,182||
|||-------------------|----------------|-------------------||
||**Total expenditure**|969,572|564,480|1,534,052||
|||=========|========|=========||
|||**Secretariat &**||**Total costs**||
|||**Staff costs**|**Other Costs**|**2019**||
||**SUPPORT COSTS COMPRISE OF:**|**£**|**£**|**£**||
||Policy & Research|51,367|202,649|254,016||
||Education|62,782|247,682|310,464||
|||----------------|---------------|------------------||
|||114,149|450,331|564,480||
|||========|=======|=========||
|**3(c)**|**OTHER COSTS INCLUDE**|||**2020**|**2019**|
|||||**£**|**£**|
||Governance costs (Note 4)|||16,470|33,001|
||Communications|||81,636|45,478|
||EASO office costs|||64,274|88,848|
||Website and marketing|||7,462|5,990|
||EOD and ECO costs|||222,263|313,503|
|||||------------------|------------------|
|||||392,105|486,820|
|||||=========|=========|



19 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|**4**.|**GOVERNANCE COSTS**|**2020**|**2019**|
|---|---|---|---|
|||**£**|**£**|
||Audit & accountancy services|16,256|14,356|
||Executive Committee meeting expenses|214|18,645|
|||-----------------|-----------------|
|||16,470|33,001|
|||========|========|
|**5.**|**NET FUNDS FOR THE YEAR**|**2020**|**2019**|
|||**£**|**£**|
||**This is stated after charging:**|||
||Auditors remuneration - charity|7,050|6,480|
||Non audit services|9,206|7,876|
|||=======|=======|
||During the year, no Trustees received any remuneration (2019 - £NIL).|||
||During the year, no Trustees received any benefits in kind (2019 - £NIL).|||
||During the year, no Trustees received reimbursement of expenses (2019 - £NIL).|||



## **6. TAXATION** 

The charitable company is exempt from corporation tax as all its income is charitable and is applied for charitable purposes. 

|**7.**|**STAFF COSTS**|**2020**|**2019**|
|---|---|---|---|
|||**£**|**£**|
||Wages and salaries|104,852|103,983|
||Social security costs|9,263|10,166|
||Pension costs|9,883|9,412|
|||----------------|----------------|
|||123,998|123,561|
|||========|========|



There was only one employee in the year, who received remuneration in the range of over £100,001 to £110,000 (2019: one in the range of £100,001 to £110,000). 

Key management personnel is the Executive Director. The total employee benefits of the key management personnel of charity were £123,997 (2019: £123,561). 

The costs above relate to the Executive Director who is the key management personnel. No benefits other than salary and pension above were received (2019: £nil). 

20 



**EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|**8.**|**DEBTORS**||**Charity**|
|---|---|---|---|
|||**2020**|**2019**|
|||**£**|**£**|
||Trade debtors|-|23,175|
||Other debtors|14,453|-|
||Prepayments and accrued income|40,534|22,124|
||Intercompany debtor|1,276|1,276|
|||-----------------|-----------------|
|||56,263|46,575|
|||**========**|**========**|
|**9.**|**CREDITORS: amounts falling due within**||**Charity**|
||**one year**|**2020**|**2019**|
|||**£**|**£**|
||Other creditors|2,292|1,606|
||Accruals|98,766|26,459|
||Deferred income|914,970|-|
||OTSS|4,032|6,556|
|||-----------------|-----------------|
|||1,020,060|34,621|
|||**========**|=========|
||**Deferred income reconciliation**|**2020**|**2019**|
|||**£**|**£**|
||Brought Forward|-|-|
||Released in the year|-|-|
||Recognised at the year end|914,970|-|
||Carried forward|-----------------|-----------------|
|||914,970|-|
|||========|========|



Deferred income in the year related to project funding received in advance of projects starting 

## **10. Post balance sheet events** 

The Charity subsidiary, EASO Trading Limited, which was incorporated in the United Kingdom was dissolved on 23 March 2021. 

21 



## **EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY** 

## **NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

|**11.**|**STATEMENTOF FUNDS**|**Brought**|**Income**|**Expenditure**|**Transfers**|**Carried**|
|---|---|---|---|---|---|---|
||**CURRENT YEAR**|**Forward**||||**Forward**|
|||**£**|**£**|**£**||**£**|
||**GENERAL FUNDS**||||||
||General charitable funds|989,564|697,791|(1,118,623)|-|568,732|
|||------------------|----------------|-----------------|-----------------|------------------|
||**Total general funds**|989,564|697,791|(1,118,623)|-|568,732|
|||=========|========|========|========|=========|
||**RESTRICTED FUNDS**||||||
||NOHOW|54,274|18,800|(12,579)|-|60,495|
||PROTEIN|104,943|36,046|(15,156)|-|125,833|
||SWEET|(5,230)|16,638|(1,750)|-|9,658|
||SOPHIA|-|4,774|-|-|4,774|
|||------------|-----------|-----------|-----------|------------|
||**Total restricted funds**|153,987|76,258|(29,485)|-|200,760|
|||======|======|======|======|======|
||**SUMMARY OF FUNDS**||||||
||General funds|989,564|697,791|(1,118,623)|-|568,732|
||Restricted funds|153,987|76,258|(29,485)|-|200,760|
|||-----------------|-----------------|-----------------|-----------------|------------------|
||**Total funds**|1,143,551|774,049|(1,148,108)|-|769,492|
|||=========|========|========|========|========|
||**STATEMENTOF FUNDS**|**Brought**|**Income**|**Expenditure**|**Transfers**|**Carried**|
||**PRIOR YEAR**|**Forward**||||**Forward**|
|||**£**|**£**|**£**||**£**|
||**GENERAL FUNDS**||||||
||General charitable funds|664,290|1,858,201|(1,484,846)|(48,081)|989,564|
|||------------------|----------------|-----------------|-----------------|------------------|
||**Total general funds**|664,290|1,858,201|(1,484,846)|-|989,564|
|||========|========|========|========|=========|
||**RESTRICTED FUNDS**||||||
||MooDFOOD|(26,090)|-|(29,991)|48,081|-|
||NOHOW|27,004|32,493|(5,223)|-|54,274|
||PROTEIN||121,705|(16,762)|-|104,943|
||SWEET|-|-|(5.230)|-|(5,230)|
|||------------|-----------|-----------|-----------|----------|
||**Total restricted funds**|914|154,198|(49,206)|48,081|153,987|
|||======|======|======|======|======|
||**SUMMARY OF FUNDS**||||||
||General funds|664,290|1,858,201|(1,484,846)|(48,081)|989,564|
||Restricted funds|914|154,198|(49,206)|48,081|153,987|
|||------------------|-----------------|-----------------|-----------------|------------------|
||**Total funds**|665,204|2,012,399|(1,534,052)|-|1,413,551|
|||=========|========|========|========|======|



22 



**ASSOCIATION FOR THE STUDY OF OBESITY** 

**NOTES TO THE FINANCIAL STATEMENTS (continued)** 

## **FOR THE YEAR ENDED 31 DECEMBER 2020** 

## **11. Restricted Funds (continued)** 

## _**Policymaker Survey**_ 

EASO was established in 2013 as a project to develop and conduct a survey of policymakers in three counties the US, UK and Spain. Supported by funding from Novo Nordisk A/A, the survey aimed to establish what different stakeholders thought about obesity and their range of views and attitudes to different issues, including causes of the problem and approaches to solving it. 

## _**NOHOW**_ 

NoHoW is a multicentre research project addressing the issue of weight loss maintenance. This project has received funding f 

## _**PROTEIN**_ 

PROTEIN is a multicentre research project addressing the issue of personalised nutrition. This project has received d innovation programme. 

## _**SWEET**_ 

SWEET is a multicentre research project addressing the issue of artificial sweeteners and wright management. This programme. 

## _**SOPHIA**_ 

The mission of the SOPHIA project is to enable healthcare professionals to reliably predict the complications of obesity and who will respond to treatment. Twenty-nine leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of obesity. The project is supported with funding of EUR 16million from the Innovative Medicines Initiative (IMI), a joint undertaking of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA),  T1D Exchange, JDRF, International Diabetes Federation (IDF) and Obesity Action Coalition. 

## **12. ANALYSIS OF NET ASSETS BETWEEN FUNDS CURRENT YEAR** 

||**Restricted**|**Unrestricted**|**Total**|
|---|---|---|---|
||**Funds**|**Funds**|**Funds**|
||**£**|**£**|**£**|
|Current assets|200,760|1,588,792|1,789,552|
|Current liabilities|-|(1,020,060)|(1,020,060)|
||----------------|------------------|------------------|
|**Net assets**|200,760|568,732|769,492|
||========|=========|=========|
|**PRIOR YEAR**||||
||**Restricted**|**Unrestricted**|**Total**|
||**Funds**|**Funds**|**Funds**|
||**£**|**£**|**£**|
|Current assets|153,987|1,024,185|1,178,172|
|Current liabilities|-|(34,621)|(34,621)|
||----------------|------------------|------------------|
|**Net assets**|153,987|989,564|1,143,551|
||========|=========|=========|



## **13. RELATED PARTY TRANSACTIONS** 

There were no related party transactions to report in either the current or prior years. 

23 

